Heterozygous familial hypercholesterolemia, Heterozygous Familial Hypercholesterolemia research hub

Study 1002-041: An Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Bempedoic Acid in Pediatric Patients (6 to 17 Years of Age) with Heterozygous Familial Hypercholesterolemia

This study is looking at a medicine called bempedoic acid for children and teenagers aged 6 to 17 who have a genetic condition called heterozygous familial hypercholesterolemia. We want to see how the medicine works in their bodies and if it's safe.